List view / Grid view
19 July 2018 | By Dr Zara Kassam (Drug Target Review)
The discovery is a major step toward understanding the mechanisms of myelin production and the potential for treating certain central nervous system diseases...
18 July 2018 | By Dr Zara Kassam (Drug Target Review)
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings...
17 July 2018 | By IDBS
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
13 July 2018 | By Drug Target Review
A new system, pGENMi, could predict genomic features associated with drug responses, by identifying differences in gene expression...
12 July 2018 | By Drug Target Review
A 3D map of genetic interactions in CVD could aid researchers investigating future treatments for heat attacks, heart failure and heart rhythm disorders.
11 July 2018 | By IDBS
This whitepaper explains how you can find ways to optimise the holistic preclinical development process...
10 July 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition...
10 July 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers have for the first time used a gene editing technique to successfully cure a genetic condition in a mouse model...
6 July 2018 | By Dr Zara Kassam (Drug Target Review)
Study raises doubts on a previous theory of Parkinson’s disease...
4 July 2018 | By Dr Zara Kassam (Drug Target Review)
Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology to correct the gene mutation responsible for AAT deficiency...
3 July 2018 | By Adam David Thomas
In the annual report of the Chief Medical Officer, 1 Dame Sally Davies has declared that we are part of ‘generation genome’ – the era in which we reap the rewards of our advances in genomic technologies and improvements in our understanding of the whole genome in human health.
3 July 2018 | By Drug Target Review
A small-molecule drug is one of the first to preserve hearing in a mouse model of an inherited form of progressive human deafness, report investigators at the University of Iowa, Iowa City, and the National Institutes of Health’s National Institute on Deafness and Other Communication Disorders (NIDCD).
3 July 2018 | By Drug Target Review
In an experiment with pigs, researchers have demonstrated for the first time that the administration of even extremely low doses of an endocrine disruptor - in this case, an endogenous oestrogen - leads to epigenetic changes in a pregnant sow’s DNA.
2 July 2018 | By Drug Target Review
Researchers have identified a new gene that plays a critical role in regulating the body's immune response to infection and disease...
29 June 2018 | By Drug Target Review
A team of researchers have identified four different mutations in the gene TRAF7...
Send this to a friend
Follow: